Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats
- PMID: 26263168
- DOI: 10.1016/j.intimp.2015.07.018
Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats
Abstract
Recent studies show that inflammation underlies the metabolic disorders of insulin resistance and type 2 diabetes mellitus. Since kaempferol, a naturally occurring flavonoid, has been described to have potent anti-inflammatory properties, we investigated whether kaempferol could ameliorate insulin resistance through inhibiting inflammatory responses. The model of diabetic rat was induced by 6-week high-fat diet plus streptozotocin. Animals were orally treated with kaempferol (50 or 150 mg/kg) and aspirin (100mg/kg) for 10 weeks. The results showed that kaempferol ameliorated blood lipids and insulin in an dose-dependent manner. Kaempferol effectively restored insulin resistance induced alteration of glucose disposal by using an insulin tolerance test and the euglycemic-hyperinsulinemic clamp method. Western blotting results showed that KPF inhibited the phosphorylation of insulin receptor substrate-1 (IRS-1), IkB kinase α (IKKα) and IkB kinase β (IKKβ). These effects were accompanied with reduction in nucleic and cytosol levels of nuclear factor kappa-β (NF-κB), and further tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels. Aspirin had similar effects. These results provide in vivo evidence that kaempferol-mediated down-regulation of IKK and subsequent inhibition of NF-κB pathway activation may be associated with the reduction of hepatic inflammatory lesions, which is contributing to the improvement of insulin signaling defect in diabetes.
Keywords: Inflammation; Insulin resistance; Kaempferol; Nuclear factor kappa-β; Rats.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.Acta Diabetol. 2008 Sep;45(3):167-78. doi: 10.1007/s00592-008-0038-7. Epub 2008 May 24. Acta Diabetol. 2008. PMID: 18500427
-
Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.Fundam Clin Pharmacol. 2017 Feb;31(1):54-63. doi: 10.1111/fcp.12231. Epub 2016 Sep 21. Fundam Clin Pharmacol. 2017. PMID: 27521287
-
Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.Atherosclerosis. 2012 Aug;223(2):350-8. doi: 10.1016/j.atherosclerosis.2012.06.012. Epub 2012 Jun 20. Atherosclerosis. 2012. PMID: 22766331
-
NF-κB pathway as a molecular target for curcumin in diabetes mellitus treatment: Focusing on oxidative stress and inflammation.Cell Biochem Funct. 2024 Jun;42(4):e4030. doi: 10.1002/cbf.4030. Cell Biochem Funct. 2024. PMID: 38720663 Review.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
Cited by
-
The Potential of Anti-Diabetic Rākau Rongoā (Māori Herbal Medicine) to Treat Type 2 Diabetes Mellitus (T2DM) Mate Huka: A Review.Front Pharmacol. 2020 Jun 30;11:935. doi: 10.3389/fphar.2020.00935. eCollection 2020. Front Pharmacol. 2020. PMID: 32694996 Free PMC article. Review.
-
Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury.Oxid Med Cell Longev. 2016;2016:7580731. doi: 10.1155/2016/7580731. Epub 2016 Mar 21. Oxid Med Cell Longev. 2016. PMID: 27087891 Free PMC article.
-
In Vivo Rodent Models of Type 2 Diabetes and Their Usefulness for Evaluating Flavonoid Bioactivity.Nutrients. 2019 Feb 28;11(3):530. doi: 10.3390/nu11030530. Nutrients. 2019. PMID: 30823474 Free PMC article. Review.
-
Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Front Pharmacol. 2021 Sep 6;12:699932. doi: 10.3389/fphar.2021.699932. eCollection 2021. Front Pharmacol. 2021. PMID: 34552482 Free PMC article.
-
Systemic elucidation on the potential bioactive compounds and hypoglycemic mechanism of Polygonum multiflorum based on network pharmacology.Chin Med. 2020 Nov 18;15(1):121. doi: 10.1186/s13020-020-00401-2. Chin Med. 2020. PMID: 33292335 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical